Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Hershey Co (HSY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Hershey Co — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Hershey Co trades at $165.99 (market cap $33.00B). The key difference: GE HealthCare Technologies Inc. Common Stock and Hershey Co are close in size by market cap, and Hershey Co pays the higher dividend (3.54%). Which is the better fit depends on your goals.
| GEHC | HSY | |
|---|---|---|
Market Cap | $30.93B | $33.00B |
Volume | 5,033,451 | 1,157,600 |
Sector | Health | Consumer Staples |
52-Week High | $88.16 | $236.28 |
52-Week Low | $59.48 | $157.61 |
Enterprise Value | $39.39B | $38.13B |
Dividend Yield | 0.23% | 3.54% |
Typical Hold Time | — | 135 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Hershey (HSY) trades at $163.05, down 0.48% with bearish technical signals including oversold RSI readings. The company shows strong profitability with 38.38% gross margins and 32.81% ROE, though 2025 net income declined to $883 million. Recent earnings beats and a $1.45 dividend payment demonstrate operational strength despite commodity cost pressures.
HSY presents a mixed outlook with analyst consensus target of $203.69 suggesting 25% upside, but technical weakness and margin compression from cocoa costs pose near-term risks. The stock's current valuation at 22.27 P/E appears reasonable for a consumer staple leader with consistent dividend payments and brand strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
